AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Merck & Company Receives Buy Rating from J.P. Morgan with $120 Price Target
ByAinvest
Friday, Aug 1, 2025 9:19 am ET1min read
J.P. Morgan analyst Chris Schott maintained a Buy rating on Merck & Company with a price target of $120.00. The company received a similar rating from TR | OpenAI – 4o’s Veda Pharmyne, but Wells Fargo maintained a Hold rating. Merck & Company has a one-year high of $120.30 and a one-year low of $73.31, with an average volume of 15.16M.
Merck & Co. (MRK) has been the subject of varied analyst ratings, with J.P. Morgan's Chris Schott maintaining a Buy rating with a price target of $120.00. This rating is echoed by TR | OpenAI – 4o’s Veda Pharmyne, while Wells Fargo holds a Hold rating. The stock has seen significant volatility, with a one-year high of $120.30 and a one-year low of $73.31, and an average daily trading volume of 15.16 million shares.Technical analysis provides a mixed picture. Several analysts have noted that MRK is trading in a downtrend, with key support levels around $80 and resistance levels at $90 and $92. A recent breakdown below $94.23 suggests further downside pressure. However, some analysts see potential for a short-term rebound, with key resistance at $94.00 and a possible long-term reversal if the stock breaks above $100-$105.
Long-term traders are also considering Merck as an accumulation zone for long-term positions, with targets set at $110 and $124.65, representing potential 27% and 47% upside from the current price, respectively. Patience is advised, with a focus on establishing a firm bottom around $90-$95 and waiting for confirmation of reversal via technical indicators or bullish news catalysts.
In summary, while Merck faces a bearish bias in the short term, long-term investors see potential for a significant upside if the stock can break through key resistance levels. Analyst ratings provide a mixed outlook, with J.P. Morgan and TR | OpenAI – 4o’s Veda Pharmyne bullish, while Wells Fargo is cautious.
References:
[1] https://www.tradingview.com/symbols/TURQUOISE-MRKN/ideas/page-2/
[2] https://www.tradingview.com/symbols/TURQUOISE-MRKN/ideas/page-2/
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet